Concord Wealth Partners Bionano Genomics, Inc. Transaction History

Concord Wealth Partners

  • $591 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 29, 2021
SELL
$44.1 - $84.0 $13,230 - $25,200
-300 Closed
0 $0
Q1 2021

May 13, 2021
BUY
$47.0 - $155.7 $14,100 - $46,710
300 New
300 $2,000

Others Institutions Holding BNGO

# of Institutions
4
Shares Held
4.97K
Call Options Held
0
Put Options Held
0
View Full List

About Bionano Genomics, Inc.

BNGO Quotes by TradingView
  • Ticker BNGO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 290,140,000
  • Market Cap $63.8M
  • Description
  • Bionano Genomics, Inc. provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel...
More about BNGO
Track This Portfolio

Track Concord Wealth Partners Portfolio

Follow Concord Wealth Partners and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concord Wealth Partners, based on Form 13F filings with the SEC.

News

Stay updated on Concord Wealth Partners with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email